Literature DB >> 325673

Endogenous E. coli endophthalmitis.

H F Shammas.   

Abstract

A case of Escherichia coli septicemia with associated metastatic en dophthalmitis and endocarditis is presented. The ocular signs and symptoms were the initial manifestations of sepsis. Irreversible damage to the eye occurred in less than 24 hours. The pattern of metastatic bacterial endophthalmitis has changed since the introduction of potent antimicrobial agents, with an increased incidence of Gram-negative bacillemia. E. coli endophthalmitis carries a poor prognosis. Early diagnosis and systemic treatment will prevent the life-threatening complications of sepsis.

Entities:  

Mesh:

Year:  1977        PMID: 325673     DOI: 10.1016/0039-6257(77)90044-3

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  5 in total

1.  Streptococcus suis type II (group R) as a cause of endophthalmitis.

Authors:  B F McLendon; A J Bron; C J Mitchell
Journal:  Br J Ophthalmol       Date:  1978-10       Impact factor: 4.638

2.  The diabetic ocular environment facilitates the development of endogenous bacterial endophthalmitis.

Authors:  Phillip S Coburn; Brandt J Wiskur; Elizabeth Christy; Michelle C Callegan
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-01       Impact factor: 4.799

3.  A case of endogenous bacterial endophthalmitis caused by Streptococcus bovis.

Authors:  Kae Hayasaka; Hideo Nakamura; Kazuhisa Hayakawa; Takeshi Gaja
Journal:  Int Ophthalmol       Date:  2007-06-30       Impact factor: 2.031

4.  Meningococcal endophthalmitis and pericarditis.

Authors:  H L Beynon; S Hague
Journal:  J R Soc Med       Date:  1990-05       Impact factor: 18.000

5.  Two cases of differentiation syndrome with ocular manifestations in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and arsenic trioxide.

Authors:  A R Newman; B Leung; A Richards; T G Campbell; J Wellwood; F R Imrie
Journal:  Am J Ophthalmol Case Rep       Date:  2018-01-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.